medigraphic.com

2010, Número 5

<< Anterior Siguiente >>

Rev Med Inst Mex Seguro Soc 2010; 48 (5)


Nefropatía por diabetes mellitus tipo 2: un rasgo multifactorial con umbral y su mapa mórbido cromosómico

Rosales-Gómez RC, López-Jiménez JJ, Núñez-Reveles NY, González-Santiago AE, Ramírez-García SA

Idioma: Español
Referencias bibliográficas: 100
Paginas: 521-530
Archivo PDF: 74.39 Kb.


RESUMEN

La nefropatía causada por la diabetes mellitus tipo 2 es un rasgo multifactorial cuyo umbral o límite para que se exprese el fenotipo depende del efecto aditivo de múltiples loci y diversos factores ambientales propios de cada población. A partir de la secuenciación del genoma humano se han encontrado más loci de susceptibilidad a través de los estudios de enlace y asociación. Los estudios de asociación muestran 69 loci involucrados, mientras que por estudios de enlace genético se han encontrado 24. Entre los factores ambientales se han informado las comidas genéticamente desconocidas y el consumo excesivo de bebidas con adulcorantes. Sin embargo, a pesar de evidencia amplia acerca del componente genético para el desarrollo de daño renal, no se descarta la participación del ambiente, evidente en algunos estudios perinatales. Uno de los abordajes que se propone dada la heterogeneidad genética que influye en la nefropatía son los estudios de epistasia, los cuales cobrarán mayor relevancia en la actualidad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Barsoum RS. A priori chronic kidney disease in the world. N Engl J Med 2006;354:997-999.

  2. García-García G, Monteón JF, García BH, Gómez NB, Reyes IH, Lomelí AM, et al. Renal replacement therapy among disadvantaged populations in Mexico: a report from the Jalisco Dialysis and Transplant Registry (Redtjal). Kidney Int 2005;97: S58-S61.

  3. Cueto-Manzano A, Cortés-Sanabria L, Martínez- Ramírez HR, Rojas-Campos E, Barragán G, Alfaro N, et al. Detection of early nephropathy in Mexican patients with type 2 diabetes mellitus. Kidney Int 2005;68:S40-S45.

  4. Tondopo B, Montero M, Coutiño M, Dávila M, Arroyo L, Ramírez P, Valencia S, et al. Detección de microalbuminuria en diabéticos tipo II. Bioquimia 2007;32;SA126.

  5. Leza-Torres O, Briones-Lara E, González- Madrazo MA, De la Cruz-Martínez MC, Ramos- Dávila E. Microalbuminuria in patients with type 2 diabetes. Rev Med IMSS 2005;43(6):487-93.

  6. González-Villalpando C, Stern MP, Arredondo B, Martínez S, Islas-Andrade S, Revilla C, et al. Nephropathy in low income diabetics: the Mexico City Diabetes Study. Arch Med Res 1996;27(3): 367-72.

  7. Rosas M, Attié F, Pastelín G, Lara A, Velázquez O, Tapia-Conyer R. Prevalance of proteinuria in Mexico: a conjunctive consolidation approach with other cardiovascular risk factors: the Mexican Health Survey 2000. Kidney Int 2005;97:S112-S119.

  8. Iseki K. Predictors of diabetic end-stage renal disease in Japan. Nephrology 2005;10;S2-S6.

  9. Burrows NR, Narva AS, Geiss LS, Engelgau MM, Acton KJ, Earle KA, et al. End stage renal disease due to diabetes among Southwestern Americans Indians. Diabetes Care 2005;28:1041-1044.

  10. Yeung VTF, Lee KF, Chan SH, Ho LF, Leung SK, Wong HY, et al. Microalbuminuria Prevalence Study (MAPS) in hypertensive type 2 diabetic patients in Hong Kong. Hong Kong Med 2006; 12(3):185-190.

  11. Chowdhury TA, Dyer P, Kumar S, Barnett AH, Brain SC. Genetic determinants of diabetic nephropathy. Clin Sci 1999;96:221-230.

  12. Minister of Health. Diabetes in Canada. National statistics and opportunities for improved surveillance, prevention, and control. Canada: Minister of Public Works and Government Services Canada; 1999.

  13. Nelson RG, Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetic kidney disease in Pima Indians. Diabetes Care 1993;16(1):335-341.

  14. Pavkov ME, Knowler WC, Bennett PH, Looker HC, Krakoff J, Nelson RG. Increasing incidence of proteinuria and declining incidence of endstage renal disease in diabetic Pima Indians. Kidney Int 2006;70(10):1840-1846.

  15. Hirata-Dulas CA, Rith-Najarian SJ, McIntyre MC, Ross C, Dahl DC, Keane WF, et al. Risk factors for nephropathy and cardiovascular disease in diabetic Northern Minnesota American Indians. Clin Nephrol 1996;46(2):92-98.

  16. Young BA, Smaynard C, Boyko EJ. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care 2003;26:2392-2399.

  17. Pettitt DJ, Daad MF, Bennet PH. Familial predisposition to renal disease in two generations of Pima Indians with type 2 diabetes mellitus. Diabetologia 1990;33:438-443.

  18. Fava S, Hatterley AT. Reported parental age of death in type 2 diabetics patients with and without established diabetic nephropathy. Eur J Intern Med 2005;16(7):482-484.

  19. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T. Is diabetic nephropathy an inherited complication? Kidney Int 1992; 41(4):719-722.

  20. Strojek K, Grzeszczak W, Morawin E, Adamski M, Lacka B, Rudzki H, Schmidt S, et al. Nephropathy of type 2 diabetes: evidence for hereditary factors. Kidney Int 1997;51:1602-1607.

  21. Satko SG, Langefeld CD, Daehag PD. Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy. Am J Kidney Dis 2002;40:489-494.

  22. Fava S, Azzopardi J, Hattersley AT, Watkins PJ. Increased prevalence of proteinuria in diabetic sibs of proteinuric type 2 diabetic subjects. Am J Kidney Dis 2000;5(4):708-712.

  23. Vijay V, Shehaltha C, Shina K. Familial aggregation of diabetic kidney disease in type 2 diabetes mellitus in South India. Diabetes Res Clin 2002;43:167-171.

  24. Agius E, Attard G, Shakespeare L, Clark P, Vidya MA, Hattersley AT, et al. Familial factors in diabetic nephropathy: an offspring study. Diabet Med 2006;23(3):331-334.

  25. McCance DR, Hanson RL, Pettitt DJ, Jacobsson LT, Bennett PH, Bishop DT, et al. Diabetic nephropathy: a risk factor for diabetes mellitus in off spring. Diabetologia 1995;38(2):221-226.

  26. Imperatore G, Knowler WC, Pettitt DJ, Kobes S, Bennett PH, Hanson RL. Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes 2000;49(6):1049-1056.

  27. Thompson CF, Simmons D, Collins JF, Cecil A. Predisposition to nephropathy in Polynesians is associated with family history of renal disease, not diabetes mellitus. Diabetes Med 2001;18(1): 40-46.

  28. Langefeld CD, Beck SR, Bowden DW, Rich SS, Wagenknecht LE, Freedman BI. Heradability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis 2004;5:796-800.

  29. Liu L, Xiang K, Zheng T, Zhang R, Li M, Li J. Coinheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy. Mol Cell Biochem 2003;254(1-2): 353-358.

  30. Lehman DM, Leach RJ, Johnson-Pais T, Hamlington J, Fowler S, Almasy L, et al. Evaluation of tight junction protein 1 encoding zona occludens 1 as a candidate gene for albuminuria in a Mexican American population. Exp Clin Endocrinol Diabetes 2006;114(8);432-437.

  31. Liang H, Murase Y, Katuta Y, Asano A, Kobayashi J, Mabuchi H. Association of LMNA 1908C/T polymorphism with cerebral vascular disease and diabetic nephropathy in Japanese men with type 2 diabetes. Clin Endocrinol 2005;63(3):317-322.

  32. Hirakawa S, Lange E, Colicigno C, Freedman B, Rich S, Borden D. Evaluation of genetic variation and association in the metalloproteinase 9 (MMP9) gene in ERSD patients. Am J Kidney Dis 2003;42(1):133-142.

  33. Red-Eagle AR, Hanson RL, Jiang W, Han X, Matters GL, Imperatore G, et al. Meprin beta metalloprotease gene polymorphisms associated with diabetic nephropathy in the Pima Indians. J Hum Genet 2007;52(2):143-151.

  34. Dos Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I. The -106CC genotype of the aldose reductase gene is associated with an increased risk of proliferative diabetic retinopathy in Caucasian-Brazilians with type 2 diabetes. Mol Genet Metab 2006;88(3):280-284.

  35. González R, Tirado A, Balanda M, Alvo M, Barquín I, Durruty P, et al. A pilot study on genetic variation in purine-rich elements in the nephrin gene promoter in type 2 diabetic patients. Biol Res 2007;40;357-364.

  36. Kanková K, Stejskalová A, Hertlová M, Znojil V. Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol Dial Transplant 2005;20:1093-1102.

  37. Ng MC, Baum L, So WY, Lam VK, Wang Y, Poon E, et al. Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3 -455T>C polymorphisms on the susceptibility to diabetic nephropathy. Clin Genet 2006;70(1):20-28.

  38. Baum L, Maggie C Y, So Wing-Yee, Lam VKL, Wang Y, Poon E, et al. Effect of hepatic lipase- 514C3T polymorphism and its interactions with apolipoprotein C3 -482C3T and apolipoprotein E exon 4 polymorphisms on the risk of nephropathy in Chinese type 2 diabetic patients. Diabetes Care 2005;28;1704-1709.

  39. Canani LH, Capp C, Daniel PK, Ng D, Serena GLC, Maia A , et al. The fatty acid-binding protein- 2 A54T polymorphism is associated with renal disease in patients with type 2 diabetes. Diabetes 2005;54:3326-3330.

  40. Jaakkola U, Pesonen U, Vainio-Jylha E, Koulu M, Pollonen M, Kallio J. The Leu7Pro polymorphism of neuropeptide Y is associated with younger age of onset of type 2 diabetes mellitus and increased risk for nephropathy in subjects with diabetic retinopathy. Exp Clin Endocrinol Diabetes 2006; 114(4):147-152.

  41. Stephens RH, McElduff P, Heald AH, New JP, Worthington J, Ollier WE, et al. Polymorphisms in IGF-binding protein 1 are associated with impaired renal function in type 2 diabetes. Diabetes 2005;54:3547-3553.

  42. Lee DY, Kim SY, Jo DS, Hwang PH, Kang KP, Lee S, et al. Preproghrelin Leu72Met polymorphism predicts a lower rate of developing renal dysfunction in type 2 diabetic nephropathy. Eur J Endocrinol 2006;155(1):187-190.

  43. Cosmo De S, Trevisan R, Dalla VM, Vedovato M, Agriolas A, Solini A, et al. PC-1 amino acid variant Q121 is associated with a lower glomerular filtration rate in type 2 diabetic patients with abnormal albumin excretion rates. Diabetes Care 2003;26: 2898-2902.

  44. Gallagher CJ, Keene KL, Mychaleckyj JC, Langefeld CD, Hirschhorn JN, Henderson BE, et al. Investigation of the estrogen receptor-alpha gene with type 2 diabetes and/or nephropathy in African- American and European-American populations. Diabetes 2007;56(3):675-684.

  45. Araki SI, Haneda M, Sugimoto T, Isono M, Isshiki K, Kashiwagi A, et al. Polymorphisms of the protein kinase C-gene (PRKCB1) accelerate kidney disease in type 2 diabetes without overt proteinuria. Diabetes Care 2006;29:864-868.

  46. Ishimitsu T, Tsukada K, Minami J, Ono H, Ohrui M, Hino J, Kangawa K. Microsatellite DNA polymorphism of human adrenomedullin gene in type 2 diabetic patients with renal failure. Kidney Int 2003;63(6):2230-2235.

  47. Shimazaki A, Kawamura Y, Kanazawa A, Sekine A, Saito S, Tsunoda T, et al. Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. Diabetes 2005;54(4):1171-1178.

  48. Caramori ML, Canani L, Costa L, Gross J. The human peroxisome proliferator-activated receptor&2 (PPAR&2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes. Diabetes 2003;52: 3010- 3013.

  49. Keene KL, Mychaleckyj JC, Smith SG, Leak TS, Perlegas PS, Langefeld CD, et al. Association of the distal region of the ectonucleotide pyrophosphatase/ phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy. Diabetes 2008;57(4):1057-1062.

  50. Yang Y, Kao MT, Chang CC, Chung SY, Chen CM, Tsai JJ, et al. Glutathione S-transferase T1 deletion is a risk factor for developing end-stage renal disease in diabetic patients. Int J Mol Med 2004;14 (5):855-859.

  51. Pinizzotto M, Castillo E, Fiaux M, Temler E, Gaillard RC, Ruiz J. Paraoxonase 2 polymorphisms are associated with nephropathy in type II diabetes. Diabetologia 2001;44(1):104-107.

  52. Murata M, Maruyama T, Suzuki Y, Saruta T, Ikeda Y. Paraoxonase 1 Gln/Arg polymorphism is associated with the risk of microangiopathy in type 2 diabetes mellitus. Diabet Med 2004;21(8):837-844.

  53. dos Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I. The catalase -262C/T promoter polymorphism and diabetic complications in Caucasians with type 2 diabetes. Dis Markers 2006;22(5-6):355-359.

  54. Lim SC, Goh SK, Lai YR, Tee WW, Koh A, Xu XH, et al. Relationship between common functional polymorphisms of the p22phox gene (-930A > G and +242C > T) and nephropathy as a result of type 2 diabetes in a Chinese population. Diabet Med 2006;23(9):1037-1041.

  55. Flekac M, Skrhaj S, Hilgertova J, Lacina Z, Jarolimkava M. Gene polymorphism of superoxide dismutase and catalase in diabetes mellitus. BMC Med Genet 2008;9:30.

  56. Prasad P, Tiwari A, Prasanna KM, Ammoni AC, Gupta A, Gupta R, et al. Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. BMC Medical Genetics 2006;7:42.

  57. Liao L, Lim MC, Chan SW, Zhao JJ, Lee KO. Nitric oxide synthase gene polymorphisms and nephropathy in Asians with type 2 diabetes. J Diabetes Complications 2006;20(6):371-375.

  58. Maltais I, Bachavarova M, Matheux P, Perron P, Marceau F, Bachavarov D. Bradykinin B2 receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients. Can J Physiol Pharmacol 2002;80(4):323-327.

  59. Prasad P, Kumar K, Ammini A, Gupta A, Gupta R, Thelma BK. Association of dopaminergic pathway gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes. BMC Genetics [en línea] 2008;9:26. Disponible en http:// www.ncbi.nlm.nih.gov/pmc/articles/PMC2287188/

  60. Buraczynska M, Ksiazek P, Baranowicz-Gaszczyk I, Jozwiak L. Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Nephrol Dial Transplant 2007;22(3): 827-832.

  61. Schjoedt KJ, Lajer M, Andersen S, Tarnow L, Rossing P, Parving HH. Aldosterone synthase (CYP11B2)-344T/C polymorphism and renopro-tective response to losartan treatment in diabetic nephropathy. Scand J Clin Lab Invest 2006;66(3): 173-180.

  62. Yeon KJ, Doo SH, Lae PB, Min Kyong MM, Min CY, HY, et al. SLC12A3 (solute carrier family 12 member sodium/chloride 3) polymorphisms are associated with end-stage renal disease in diabetic nephropathy. Diabetes 2006;55:843-848.

  63. Muczuski D, Greszczak W, Gawlik B. Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy. Diabetes Care 2001; 24:1187-1191.

  64. Nakajima K, Tanaka Y, Niniyama T, Oghiara T, Ikeda F, Kanno R, et al. RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects. Diabetes Care 2003; 26:892-898.

  65. Prasad P, Tiwari AK, Kumar KM, Ammini AC, Gupta A, Gupta R, Thelma BK. Association of TGFbeta1, TNFalpha, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians. BMC Med Genet 2007;8:20.

  66. Kitamura A, Hasegawa G, Obayashi H, Kamiuchi K, Ishii M, Yano M, et al. Interleukin-6 polymorphism (-634 C/G) in the promoter region and progression of diabetic nephropathy in type 2 diabetes. Diabetes 2002;19(12):1000-1005.

  67. Liu Y, Burdon KP, Langefeld CD, Beck SR, Wagenknecht LE, Rich SS, et al. Pselectin gene haplotype associations with albuminuria in the Diabetes Heart Study. Kidney Int 2005;68(2):741-746.

  68. Kamiuchi K, Hasegawa G, Obayashi H, Kitamura A, Ishii M, Yano M. Leukocyte- endothelial cell adhesion molecule 1 (LECAM-1) polymorphism is associated with diabetic nephropathy in type 2 diabetes mellitus. J Diabetes Complications 2002;16(5):333-337.

  69. Liu SQ, Xue YM, Yang GC, He FY, Zhao XS. Relation between plasminogen activator inhibitor-1 gene 4G/5G polymorphism and type 2 diabetic nephropathy in Chinese Han patients in Guangdong Province. Fiyi Juan Ya Da Xue Bajo 2004;24(8):904-907.

  70. Young J, Jean g L, Lee S, Jung K, Lee T, Chn-Gyon I, et al. Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean Patients with type 2 diabetes mellitus. J Korean Med Sci 2007; 22:810-814.

  71. Abrahamian H, Endler G, Exner M, Mauler H, Raith M, Endler L, et al. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines. Exp Clin Endocrinol Diabetes 2007;115(1):38-41.

  72. Buraczynska M, Baranowicz-Gaszczyk I, Borowicz E, Ksiazek A. TGF-beta1 and TSC-22 gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes. Nephron Physiol 2007;106(4):69-75.

  73. Sale M, Smith S, Mychaleckyj J, Keene K, Langefeld C, Leak T, et al. Variants of the transcription factor 7-Like 2 (TCF7L2) gene are associated with type 2 diabetes in an African American population enriched for nephropathy. Diabetes 2007; 56:2638-2642.

  74. Prasad P, Tiwari AK, Kumar KM, Ammini AC, Gupta A, Gupta R, et al. Association analysis of ADPRT1, AKR1B1, RAGE, GFPT2 and PAI-1 gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes. BMC Med Genet; 2010;31(11):52. Disponible en http://www.ncbi.nlm. nih.gov/pmc/articles/PMC2855532/

  75. Maeda S, Kobayashi MA, Araki S, Babazono T, Freedman BI, Bostrom MA, et al. A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes. PLoS Genet 2010;6(2):e1000842.

  76. Ohshige T, Tanaka Y, Araki S, Babazono T, Toyoda M, Umezono T, et al. A single nucleotide polymorphism in KCNQ1 is associated with susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes. Diabetes Care 2010;33(4):842-846.

  77. Stefanidis I, Kytoudis K, Papathanasiou AA, Zaragotas D, Melistas L, Kitsios GD, et al. XbaI GLUT1 gene polymorphism and the risk of type 2 diabetes with nephropathy. Dis Markers 2009;27(1):29-35.

  78. Ukinc K, Ersoz HO, Karahan C, Erem C, Eminagaoglu S, Hacihasanoglu AB, et al. Methyltetra-hydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy. Endocrine 2009;36 (2):255-261.

  79. Freedman BI, Hicks PJ, Bostrom MA, Comeau ME, Divers J, Bleyer AJ, et al. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol Dial Transplant 2009;24(11):3366-3371.

  80. Wu LS, Hsieh CH, Pei D, Hung YJ, Kuo SW, Lin E. Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPARgamma and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes. Nephrol Dial Transplant 2009;24(11):3360-3366.

  81. McDonough CW, Hicks PJ, Lu L, Langefeld CD, Freedman BI, Bowden DW. The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans. Hum Genet 2009;126(2):265-275.

  82. Hatunic M, Stapleton M, Hand E, DeLong C, Crowley VE, Nolan JJ. The Leu262Val polymorphism of presenilin associated rhomboid like protein (PARL) is associated with earlier onset of type 2 diabetes and increased urinary microalbumin creatinine ratio in an Irish case-control population. Diabetes Res Clin Pract 2009;83(3):316-319.

  83. Szoke D, Molnar B, Solymosi N, Racz K, Gergics P, Blasko B, et al. Polymorphisms of the ApoE, HSD3B1, IL-1beta and p53 genes are associated with the development of early uremic complications in diabetic patients: results of a DNA resequencing array study. Int J Mol Med. 2009; 23(2):217-27.

  84. Liu Y, Freedman BI, Burdon KP, Langefeld CD, Howard T, Herrington D, et al. Association of arachidonate 12-lipoxygenase genotype variation and glycemic control with albuminuria in type 2 diabetes. Am J Kidney Dis 2008;52 (2):242-250.

  85. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group Diabetes 1998;47(5):821-830.

  86. Bowden DW, Sale M, Howard TD, Qadri A, Spray BJ, Rothschild CB, et al. Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes1997;46(5):882-886.

  87. Vardarli I, Baier LJ, Hanson RL, Akkoyun I, Fischer C, Rohmeiss P, et al. Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 2002; 62(6):2176-2183.

  88. Chen G, Adeyemo AA, Zhou J, Chen Y, Doumatey A, et al. A genome-wide search for linkage to renal function phenotypes in West Africans with type 2 diabetes. Am J Kidney Dis 2007;49(3):394-400.

  89. Leak TS, Langefeld CD, Keene KL, Gallagher CJ, Lu L, Mychaleckyj JC, et al. Chromosome 7p linkage and association study for diabetes related traits and type 2 diabetes in an African-American population enriched for nephropathy. BMC Med Genet 2010;11:22.

  90. Malhotra A, Igo RP Jr, Thameem F, Kao WH, Abboud HE, Adler SG, et al. Genome-wide linkage scans for type 2 diabetes mellitus in four ethnically diverse populations-significant evidence for linkage on chromosome 4q in African Americans: the Family Investigation of Nephropathy and Diabetes Research Group. Diabetes Metab Res Rev 2009;25(8):740-747.

  91. Hsieh CH, Liang KH, Hung YJ, Huang LC, Pei D, Llao YT, et al. Analysis of epistasis for diabetic nephropathy among type 2 diabetic patients. Hum Mol Gen 2006;15(18):2701-2708.

  92. Nannipeieri M, Posadas R, Williams K, Polit E, Gonzalez-Villalpando C, Stern M, et al. Association between polymorphism of the atrial natruretic peptide gene and proteinuria; a population based study. Diabetologia 2003;46(3):429-432.

  93. Palomo-Piñón S, Gutiérrez-Rodríguez ME, Díaz- Flores M, Sánchez-Barrera R, Valladares-Salgado A, Utrera-Barillas D, et al. DD genotype of angiotensin- converting enzyme in type 2 diabetes mellitus with renal disease in Mexican mestizos. Nephrology 2009;14(2):235-239.

  94. Ortega-Pierres LE, Gómez-García A, Rodríguez- Ayala E, Figueroa-Núñez B, Farías-Rodríguez VM, Higareda-Mendoza AE, et al. Angiotensin-1 converting enzyme insertion/deletion gene polymorphism in a Mexican population with diabetic nephropathy. Med Clin 2007;129(1):6-10.

  95. Crespo MN, Padilla GJ, Crespo VN, Importancia de la microalbuminuria en la diabetes mellitus Rev Cubana Med Gen Integr [en línea] 2002;(5): 55-71.

  96. Licea PM, Figueredo SE, Perich AP, Cabrera RE. Frecuencia y características clínicas de la nefropatía incipiente en personas con diabetes mellitus tipo 2 de diagnóstico reciente. Rev Cubana Endocrinol [en línea] 2003;14(1).

  97. Hitchins M, Moore G. Genomic imprinting in fetal growth and development. Expert Rev Mol Med 2002;4(11):1-19.

  98. Rudberg S. Perinatal factors can be risk factors of diabetic nephropathy. Lakartidningen 2000;26; 97(4):317-319.

  99. Nelson RG, Morgenstem H, Bennett PH. Birth weight and renal disease in Pima Indians with type 2 diabetes mellitus. Am J Epidemiol 1998; 148(7):650-656.

  100. Baschetti R. Diabetes epidemic in newly westernized populations: is it due to thrifty genes or to genetically unknown foods? J R Soc Med 1998;91(12):622-625.




2020     |     www.medigraphic.com